| Entry |
|
|---|
| Name |
Zenarestat (USAN/INN) |
|---|
| Formula |
C17H11BrClFN2O4
|
|---|
| Exact mass |
439.9575
|
|---|
| Mol weight |
441.6356
|
|---|
| Structure |
|
|---|
| Class |
Antidiabetic agent
DG01882 Aldose reductase inhibitor
|
|---|
| Efficacy |
Hypoglycemic, Aldose reductase inhibitor |
|---|
| Comment |
Treatment of diabetic neuropathy
|
|---|
| Target |
|
|---|
| Pathway |
| hsa00051 | Fructose and mannose metabolism |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01882 Aldose reductase inhibitor
D03807 Zenarestat
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
AKR1B1
D03807 Zenarestat (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 26
1 C8y C 31.6822 -18.9530
2 C8y C 31.6822 -20.3518
3 N4y N 32.8712 -18.2536
4 C8x C 30.4933 -18.2536
5 C8y C 32.8712 -21.0511
6 C8x C 30.4933 -21.0511
7 C8y C 34.0601 -18.9530
8 C1b C 32.8712 -16.8549
9 C8y C 29.2344 -18.9530
10 N4y N 34.0601 -20.3518
11 O5x O 32.8712 -22.4499
12 C8x C 29.2344 -20.3518
13 C6a C 34.0601 -16.1555
14 O6a O 35.3190 -16.8549
15 O6a O 34.0601 -14.7568
16 C1b C 35.3190 -21.0511
17 C8y C 36.5079 -20.3518
18 C8y C 37.6968 -21.0511
19 C8x C 38.9557 -20.3518
20 C8y C 38.9557 -18.9530
21 C8x C 37.6968 -18.2536
22 C8x C 36.5079 -18.9530
23 X F 37.6968 -22.4499
24 X Br 40.1446 -18.2536
25 X Cl 28.0289 -18.2436
26 O5x O 35.2743 -18.2585
BOND 28
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 5 10 1
10 5 11 2
11 6 12 2
12 8 13 1
13 13 14 1
14 13 15 2
15 7 10 1
16 9 12 1
17 10 16 1
18 16 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 17 22 1
25 18 23 1
26 20 24 1
27 9 25 1
28 7 26 2
|
|---|
